Many 2013 Outing sponsors met on a chilly February evening at the CSHL for an evening of appreciation. To the backdrop of a photo presentation of the 1st Outing and T.J.’s life, donors enjoyed a glass of wine, a few words of thanks from Tom Arcati and a speech from Dr. Bruce Stillman about plans for the ambitious research project.
The highlight of the evening was a tour of the Demerec Lab. Our donors were able to view a working lab and experience a rare opportunity to be inside the halls of research. Although difficult to understand for most, everyone left with a better understanding and appreciation for the work involved. Some expressed an appreciation for seeing the work in progress rather than just hearing or reading about it.
Cycle for Survival is the high-energy indoor team cycling event that provides a tangible way to beat rare cancers. The event supports research for many rare cancers.
Cycle 4 Survival 2012
Fundraiser for Rare Cancers. Equinox Gym, New York City. 2012
See images »
More than half of people diagnosed with cancer have a rare form of the disease.
According to the National Institutes of Health (NIH), a “rare cancer” is one with a prevalence for fewer than 20,000 affected individuals in the United States. Research on many rare cancers is drastically underfunded, leaving patients with limited treatment options. Memorial Sloan-Kettering Cancer Center, the nation’s preeminent center for cancer research and treatment, is committed to changing that.
100% Goes to Win the Battle
Cycle for Survival’s indoor team cycling event raises funds for rare cancer research.
100% of the funds go directly to Memorial Sloan-Kettering Cancer Center and are allocated within six months of each event. The donations go to the most promising research and clinical trials, and have led to better treatments for cancer patients worldwide. If you want to actively fight cancer, join the battle with us.
Since its inception in 2007, Cycle for Survival has raised over $32.4 million for rare cancer research and contributed to 85 clinical trials and research studies. The direct funding has drastically reduced the time it takes for treatments to reach patients – in some cases cutting the span from years to months.
Doctors and researchers who’ve received Cycle for Survival funding credit these resources for making groundbreaking discoveries possible, advancing vital research where – sometimes – little to no funding exists.